tiprankstipranks
Trending News
More News >
Idorsia Ltd (IDRSF)
OTHER OTC:IDRSF
US Market
Advertisement

Idorsia Ltd (IDRSF) Stock News & Sentiment

Compare
20 Followers
Idorsia’s Growth Potential Bolstered by Aprocitentan Approval and Strategic Commercialization Efforts
Premium
Ratings
Idorsia’s Growth Potential Bolstered by Aprocitentan Approval and Strategic Commercialization Efforts
27d ago
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Idorsia Ltd, with a price target of CHF6.00. Ram Selvaraju has given his Buy rating ...Read more
Idorsia Ltd Earnings Call: Strong Growth Amid Challenges
Premium
Company Announcements
Idorsia Ltd Earnings Call: Strong Growth Amid Challenges
3M ago
Idorsia Ltd Earnings Call: Balancing Challenges and Growth
Premium
Company Announcements
Idorsia Ltd Earnings Call: Balancing Challenges and Growth
7M ago

News Score - Last 7 Days

Neutral
IDRSF
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IDRSF’s Media Buzz Sentiment?
1 articles about IDRSF were published this week. In an average week, 1 articles are published.
    What is IDRSF’s weekly average amount of articles?
    In an average week, 1 articles about IDRSF are published.
      What is IDRSF’s News Sentiment?
      50% of articles about IDRSF were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        ALNYAlnylam Pharma
        IXIIXICO plc
        ANIPANI Pharmaceuticals
        TDOCTeladoc
        ZTSZoetis
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis